Artificial Intelligence (AI) in Drug Discovery Market Size, Growth, Share, Trends – Designer Women
The latest update on Worldwide Artificial Intelligence (AI) in Drug Discovery Market The study provides comprehensive and valuable insights into market development activities demonstrated by industry players, growth opportunities, and market size for Artificial intelligence (AI) in drug discovery, with an analysis by key segments, leading and emerging players, and geographies (2022-2029). The 350-page study covers the detailed business overview of each profiled player, its comprehensive research and market development history along with the latest news and press releases. . It also offers detailed information about market size, share, growth, trends, demand product, key players, various applications and major geographical regions.
Market analysis and size
Artificial Intelligence (AI) is described as a machine that uses advanced technologies to perform activities related to the human mind. The main goal of drug discovery research is to find drugs that can help in the prevention or treatment of specific diseases. The challenges of examining, collecting and applying data to solve difficult medical problems in the pharmaceutical sector have fueled the demand for artificial intelligence (AI) in the drug discovery market.
Data Bridge Market Research analyzes that the Artificial Intelligence (AI) in Drug Discovery Market is expected to reach a value of USD 7,818.93 Million by 2029, growing at a CAGR of 41.0% during the period forecast. Extensive applications of artificial intelligence in various fields of drug discovery including polypharmacology, chemical synthesis, drug screening, drug design, and drug reuse are expected to significantly drive the market growth.
Connect with market leaders and emerging artificial intelligence (AI) players in the drug discovery market.
Download Sample PDF Copy of This Report (Including Full Table of Contents, List of Tables and Figures, Chart)@ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-artificial-intelligence-ai-in-drug-discovery-market
(Sample of this report is readily available on demand with Impact of COVID-19 on this Industry)
Content of this sample report:
• A brief introduction to this research scope and methodology.
• Revenue analysis of leading and emerging players.
• Key highlights of growth drivers and market trends.
• Key overview of the final study.
Graphic illustration of regional analysis.
Scope/Segmentation of Artificial Intelligence (AI) in Drug Discovery Market
By offering (software, services),
By technology (machine learning, other technologies)
By drug type (small molecule, large molecule)
By application (immuno-oncology, neurodegenerative diseases, cardiovascular diseases, metabolic diseases, other applications)
By end user (pharmaceutical and biotechnology companies, contract research organizations, research centers and academic and government institutes)
Obviously maintaining the status quo will not drive growth, now a lot of Artificial Intelligence (AI) in drug discovery makers are seen entering new markets and then looking for revenue and revenue growth. results from overseas investments. Data Bridge Market Research has covered more than 20 country-level analysis in Global Artificial Intelligence (AI) in Drug Discovery Market Regional coverage.
To learn more about the study @ https://www.databridgemarketresearch.com/reports/global-artificial-intelligence-ai-in-drug-discovery-market
Geographically, the global version of the Artificial Intelligence (AI) in Drug Discovery Market report covers the following regions and countries
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Netherlands, Belgium, Spain, Russia, Italy and rest of Europe)
Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia and others)
South America (Brazil, Argentina, Colombia, Others)
MEA (Saudi Arabia, Turkey, United Arab Emirates (UAE), Israel, Egypt, South Africa and Rest of MEA)
The Artificial Intelligence (AI) in Drug Discovery market report is provided for the international markets as well as development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report further states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. Third by regions, this report focuses on sales (consumption), production, import and export of Artificial Intelligence (AI) in Drug Discovery in United States, Europe, China, Japan and Southeast Asia, India.
Some of the key players operating in the Artificial Intelligence (AI) in Drug Discovery Market Report are
Exscientia plc, Microsoft, NVIDIA Corporation, IBM, Cyclica, Atomwise, Inc., DEEP GENOMICS, Cloud Pharmaceuticals, Inc., Insilico Medicine, BenevolentAI Ltd., Aria Pharmaceuticals, Inc., NuMedii….
The full report is available (including full table of contents, list of tables and figures, charts and graph) https://www.databridgemarketresearch.com/toc/?dbmr=global-artificial-intelligence-ai-in-drug-discovery-market
Data source and research methodology:
Our analysts compiled the report by gathering information through primary (through surveys and interviews) and secondary (including databases of industry bodies, reputable paid sources and trade journals). The report includes a comprehensive qualitative and quantitative assessment. The study includes growth trends, micro and macro economic indicators, regulations and government policies.
Facing the challenges facing the industry, the Artificial Intelligence (AI) in Drug Discovery market study discusses and sheds light on:
– The resulting insight to understand why and how the global Artificial Intelligence (AI) in Drug Discovery industry is expected to change.
– Where is the artificial intelligence (AI) industry heading in drug discovery and what are the top priorities. To craft it, Data Bridge Market Research turned to manufacturers to derive insights such as financial analysis, investigation of artificial intelligence (AI) in drug discovery companies, and interviews with upstream suppliers and downstream buyers and industry experts.
– How Artificial Intelligence (AI) in the drug discovery company in this diverse set of players can better navigate the new emerging industry landscape and develop a strategy to gain market position.
Global Artificial Intelligence (AI) in Drug Discovery Market Scope
The artificial intelligence (AI) in drug discovery market is segmented on the basis of supply, technology, drug type, application, and end-user. The growth among these segments will help you analyze weak growth segments in the industries and provide users with valuable market insight and market insights to help them make strategic decisions to identify major applications of the market.
On the basis of supply, the artificial intelligence (AI) in drug discovery market is segmented into software and services.
On the basis of technology, artificial intelligence (AI) in drug discovery market is segmented into machine learning and other technologies. Machine learning has been segmented into deep learning, supervised learning, reinforcement learning, unsupervised learning, and other machine learning technologies.
Type of drug
On the basis of drug type, artificial intelligence (AI) in drug discovery market is segmented into small molecule and large molecule.
On the basis of applications, the artificial intelligence (AI) in drug discovery market is segmented into immuno-oncology, neurodegenerative diseases, cardiovascular diseases, metabolic diseases and other applications.
Pharmaceutical and biotechnology companies
Contract research organizations
Research centers and universities
Artificial intelligence (AI) in drug discovery market has also been segmented based on end-user into pharmaceutical and biotechnology companies, contract research organizations, research centers, and academic and government institutes.
Excerpt from TOC of Artificial Intelligence (AI) in Drug Discovery Market:
a. Study assumptions
b. Scope of the study
2. Research methodology
3. Executive Summary
4. Market dynamics
a. Market factors
b. Market constraints
vs. Industry Attractiveness – Porter’s Five Forces Analysis
5. Market segmentation
6. Competitive landscape
a. Supplier market share
b. Company Profiles
7. Market opportunities and future trends
8. Industry Chain, Downstream Buyers and Sourcing Strategy
9. Marketing Strategy Analysis
Browse the abstract and full table of contents @ https://www.databridgemarketresearch.com/toc/?dbmr=global-artificial-intelligence-ai-in-drug-discovery-market
DBMR Healthcare Domain Reports:
Global Prenatal Genetic Counseling Market-https://www.einnews.com/pr_news/575866469/prenatal-genetic-counselling-market-2022-industry-share-size-key-growth-drivers-trends-segments-opportunity-to-2029
Global Healthcare Fraud Detection Market-https://www.einpresswire.com/article/576021794/healthcare-fraud-detection-market-2022-global-industry-trends-component-technology-regional-overview-2029-insight
Global Healthcare Facility Management Market-https://www.einpresswire.com/article/576029374/healthcare-facilities-management-market-2022-on-going-trends-revenue-siz-share-growth-prominent-players-2028